Healthcare Stocks
✓ Ranked directly from Yahoo Finance data · Checked for accuracy at every rebuild · Snapshot: 6 September 2026 · Updated: 28 October 2026
All 267 companies in our Healthcare listing.
Largest by Market Cap
| # | Ticker | Company | Market Cap |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | $1.02T |
| 2 | JNJ | Johnson & Johnson | $663.28B |
| 3 | ABBV | AbbVie Inc. | $453.19B |
| 4 | MRK | Merck & Co., Inc. | $370.89B |
| 5 | UNH | UnitedHealth Group Incorporated | $356.47B |
| 6 | AMGN | Amgen Inc. | $236.38B |
| 7 | TMO | Thermo Fisher Scientific Inc. | $226.94B |
| 8 | ABT | Abbott Laboratories | $187.45B |
| 9 | GILD | Gilead Sciences, Inc. | $187.23B |
| 10 | AZN | AstraZeneca PLC | £186.20B |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
AMAZON
One Up On Wall Street
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →
AMAZON
Financial Planner Organizer
Keep budgets, portfolios and goals in one place with a dedicated finance planner.
Check Price →
AMAZON
Buffett: The Making of an American Capitalist
Roger Lowenstein's definitive biography of the world's most famous investor.
Check Price →Frequently Asked Questions
- Why is healthcare often considered a defensive sector?
- Demand for medical treatment doesn't disappear in a recession the way discretionary spending does, so healthcare revenue tends to be more stable through economic downturns than cyclical sectors.
- Why can healthcare stocks be volatile despite being "defensive"?
- Individual companies face binary risks unrelated to the economy — a clinical trial failing, a regulator rejecting a drug, or a patent expiring and opening the door to generic competition — that can move a single stock sharply regardless of broader market conditions.
- What's the difference between pharma, biotech and medical device companies here?
- Pharmaceutical and biotech companies develop drugs (biotech skews toward earlier-stage, higher-risk research), while medical device and healthcare service companies sell equipment or provide care — all sit within this one sector despite very different risk profiles.
- Do healthcare companies typically pay dividends?
- Large, established pharmaceutical companies often do, while earlier-stage biotech companies — frequently pre-profit — typically do not. Check the Dividend Yield column in the table below.
- Where does this sector data come from?
- Data is sourced directly from Yahoo Finance as a periodic snapshot, dated on this page. This is a reference tool for research, not investment advice.
All Healthcare Stocks
| # | Ticker | Company | Price | Market Cap | P/E | Dividend Yield |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | $1,149.36 | $1.02T | 38.61 | 0.60% |
| 2 | JNJ | Johnson & Johnson | $275.23 | $663.28B | 31.97 | 1.95% |
| 3 | ABBV | AbbVie Inc. | $256.46 | $453.19B | 72.45 | 2.70% |
| 4 | MRK | Merck & Co., Inc. | $150.33 | $370.89B | 120.26 | 2.23% |
| 5 | UNH | UnitedHealth Group Incorporated | $397.14 | $356.47B | 25.51 | 2.34% |
| 6 | AMGN | Amgen Inc. | $437.23 | $236.38B | 27.17 | 2.31% |
| 7 | TMO | Thermo Fisher Scientific Inc. | $613.78 | $226.94B | 33.00 | 0.31% |
| 8 | ABT | Abbott Laboratories | $108.33 | $187.45B | 35.06 | 2.33% |
| 9 | GILD | Gilead Sciences, Inc. | $151.00 | $187.23B | — | 2.17% |
| 10 | AZN | AstraZeneca PLC | £120.06 | £186.20B | 24.35 | 1.97% |
| 11 | PFE | Pfizer Inc. | $28.45 | $162.16B | 37.43 | 6.05% |
| 12 | DHR | Danaher Corporation | $207.66 | $145.98B | 37.02 | 0.77% |
| 13 | VRTX | Vertex Pharmaceuticals Incorporated | $546.12 | $138.42B | 31.84 | — |
| 14 | BMY | Bristol-Myers Squibb Company | $66.82 | $136.49B | 14.72 | 3.77% |
| 15 | ISRG | Intuitive Surgical, Inc. | $366.70 | $131.38B | 42.00 | — |
| 16 | CVS | CVS Health Corporation | $96.74 | $123.73B | 25.53 | 2.75% |
| 17 | MDT | Medtronic plc | $94.17 | $120.46B | 23.19 | 3.06% |
| 18 | SYK | Stryker Corporation | $303.13 | $116.27B | 31.45 | 1.16% |
| 19 | MCK | McKesson Corporation | $907.99 | $105.86B | 24.33 | 0.41% |
| 20 | ELV | Elevance Health, Inc. | $407.50 | $88.37B | 18.02 | 1.69% |
| 21 | HCA | HCA Healthcare, Inc. | $405.00 | $87.68B | 13.59 | 0.77% |
| 22 | REGN | Regeneron Pharmaceuticals, Inc. | $827.72 | $85.22B | 20.49 | 0.45% |
| 23 | CI | The Cigna Group | $282.52 | $74.65B | 11.68 | 2.21% |
| 24 | GSK | GSK plc | £18.46 | £73.96B | 15.65 | 3.68% |
| 25 | BSX | Boston Scientific Corporation | $47.80 | $69.27B | 19.35 | — |
| 26 | COR | Cencora, Inc. | $330.95 | $63.15B | 24.57 | 0.73% |
| 27 | MRNA | Moderna, Inc. | $145.55 | $58.11B | — | — |
| 28 | CAH | Cardinal Health, Inc. | $247.18 | $57.49B | 34.24 | 0.83% |
| 29 | EW | Edwards Lifesciences Corporation | $89.90 | $51.82B | 53.51 | — |
| 30 | BDX | Becton, Dickinson and Company | $184.74 | $50.32B | 31.96 | 2.27% |
| 31 | HUM | Humana Inc. | $401.54 | $48.22B | 38.02 | 0.88% |
| 32 | NTRA | Natera, Inc. | $328.18 | $47.31B | — | — |
| 33 | VEEV | Veeva Systems Inc. | $275.09 | $44.54B | 45.02 | — |
| 34 | IQV | IQVIA Holdings Inc. | $267.77 | $44.07B | 33.35 | — |
| 35 | A | Agilent Technologies, Inc. | $150.86 | $42.54B | 29.76 | 0.68% |
| 36 | TEVA | Teva Pharmaceutical Industries Limited | $36.36 | $42.37B | 60.60 | — |
| 37 | IDXX | IDEXX Laboratories, Inc. | $535.38 | $42.18B | 37.60 | — |
| 38 | WAT | Waters Corporation | $409.38 | $40.20B | 104.17 | — |
| 39 | RPRX | Royalty Pharma plc | $63.96 | $36.96B | 34.39 | 1.47% |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | $266.11 | $35.61B | 46.28 | — |
| 41 | ALC | Alcon Inc. | $70.50 | $34.08B | 53.82 | 0.51% |
| 42 | DXCM | DexCom, Inc. | $87.90 | $33.17B | 34.74 | — |
| 43 | CNC | Centene Corporation | $67.04 | $33.12B | — | — |
| 44 | ILMN | Illumina, Inc. | $218.22 | $32.95B | 40.64 | — |
| 45 | RMD | ResMed Inc. | $228.35 | $32.94B | 21.87 | 1.16% |
| 46 | BIIB | Biogen Inc. | $220.83 | $32.63B | 39.22 | — |
| 47 | ZTS | Zoetis Inc. | $75.81 | $31.33B | 12.37 | 2.80% |
| 48 | GEHC | GE HealthCare Technologies Inc. | $68.86 | $31.10B | 15.87 | 20.00% |
| 49 | HLN | Haleon plc | £3.53 | £31.03B | 19.60 | 2.04% |
| 50 | INSM | Insmed Incorporated | $126.29 | $27.58B | — | — |
| 51 | MTD | Mettler-Toledo International Inc. | $1,345.26 | $26.95B | 30.31 | — |
| 52 | LH | Labcorp Holdings Inc. | $326.89 | $26.51B | 27.04 | 0.88% |
| 53 | DGX | Quest Diagnostics Incorporated | $237.14 | $26.17B | 25.20 | 1.44% |
| 54 | INCY | Incyte Corporation | $126.75 | $25.69B | 16.15 | — |
| 55 | WST | West Pharmaceutical Services, Inc. | $339.97 | $23.93B | 43.47 | 0.26% |
| 56 | STE | STERIS plc | $224.59 | $21.90B | 27.46 | 1.15% |
| 57 | THC | Tenet Healthcare Corporation | $265.05 | $21.34B | 10.25 | — |
| 58 | UTHR | United Therapeutics Corporation | $487.61 | $20.91B | 17.48 | — |
| 59 | VTRS | Viatris Inc. | $16.88 | $19.39B | — | 2.84% |
| 60 | ZBH | Zimmer Biomet Holdings, Inc. | $98.07 | $18.71B | 23.80 | 0.98% |
| 61 | MEDP | Medpace Holdings, Inc. | $591.29 | $16.50B | 34.72 | — |
| 62 | JAZZ | Jazz Pharmaceuticals plc | $246.81 | $16.02B | 16.89 | — |
| 63 | NBIX | Neurocrine Biosciences, Inc. | $155.64 | $15.82B | 22.79 | — |
| 64 | SOLV | Solventum Corporation | $91.69 | $15.61B | 11.21 | — |
| 65 | EXEL | Exelixis, Inc. | $59.01 | $14.62B | 18.56 | — |
| 66 | RVTY | Revvity, Inc. | $130.22 | $14.53B | 62.61 | 0.22% |
| 67 | CRL | Charles River Laboratories International, Inc. | $288.50 | $13.90B | — | — |
| 68 | COO | The Cooper Companies, Inc. | $69.59 | $13.57B | 58.97 | — |
| 69 | BAX | Baxter International Inc. | $25.83 | $13.35B | — | 15.00% |
| 70 | BMRN | BioMarin Pharmaceutical Inc. | $66.53 | $12.88B | 179.81 | — |
| 71 | PEN | Penumbra, Inc. | $322.17 | $12.69B | 79.35 | — |
| 72 | HALO | Halozyme Therapeutics, Inc. | $110.19 | $12.51B | 32.31 | — |
| 73 | MDGL | Madrigal Pharmaceuticals, Inc. | $541.08 | $12.50B | — | — |
| 74 | CORT | Corcept Therapeutics Incorporated | $111.62 | $12.07B | 248.04 | — |
| 75 | DVA | DaVita Inc. | $183.99 | $11.74B | 15.61 | — |
| 76 | TECH | Bio-Techne Corporation | $72.43 | $11.36B | 62.44 | 0.44% |
| 77 | ALGN | Align Technology, Inc. | $158.63 | $11.27B | 27.54 | — |
| 78 | GMED | Globus Medical, Inc. | $78.29 | $10.51B | 20.02 | — |
| 79 | MOH | Molina Healthcare, Inc. | $200.80 | $10.48B | 1,255.00 | — |
| 80 | GKOS | Glaukos Corporation | $177.47 | $10.47B | — | — |
| 81 | BIO | Bio-Rad Laboratories, Inc. | $386.11 | $10.32B | 46.97 | — |
| 82 | PODD | Insulet Corporation | $147.48 | $10.23B | 27.62 | — |
| 83 | AVTR | Avantor, Inc. | $14.97 | $10.13B | — | — |
| 84 | CYTK | Cytokinetics, Incorporated | $72.72 | $10.11B | — | — |
| 85 | HSIC | Henry Schein, Inc. | $89.81 | $10.01B | 26.18 | — |
| 86 | UHS | Universal Health Services, Inc. | $169.65 | $10.00B | 6.92 | 0.47% |
| 87 | ENSG | The Ensign Group, Inc. | $170.79 | $9.95B | 26.73 | 15.00% |
| 88 | IONS | Ionis Pharmaceuticals, Inc. | $58.09 | $9.65B | — | — |
| 89 | RGEN | Repligen Corporation | $167.60 | $9.46B | 226.49 | — |
| 90 | PTGX | Protagonist Therapeutics, Inc. | $145.72 | $9.43B | 141.48 | — |
| 91 | QGEN | Qiagen N.V. | $43.47 | $8.98B | 22.07 | 0.81% |
| 92 | BRKR | Bruker Corporation | $58.50 | $8.91B | — | 0.34% |
| 93 | SN | Smith & Nephew plc | £10.64 | £8.91B | 19.70 | 2.76% |
| 94 | TGTX | TG Therapeutics, Inc. | $55.98 | $8.57B | 20.43 | — |
| 95 | ATR | AptarGroup, Inc. | $127.41 | $8.10B | 23.00 | 1.51% |
| 96 | HQY | HealthEquity, Inc. | $96.07 | $7.95B | 34.68 | — |
| 97 | ALKS | Alkermes plc | $46.10 | $7.73B | 121.32 | — |
| 98 | CHE | Chemed Corporation | $519.84 | $6.79B | 26.18 | 0.54% |
| 99 | LNTH | Lantheus Holdings, Inc. | $100.97 | $6.59B | 24.16 | — |
| 100 | COGT | Cogent Biosciences, Inc. | $34.76 | $6.03B | — | — |
| 101 | TFX | Teleflex Incorporated | $138.36 | $5.86B | — | 0.98% |
| 102 | RDNT | RadNet, Inc. | $73.71 | $5.80B | — | — |
| 103 | PTCT | PTC Therapeutics, Inc. | $69.30 | $5.78B | — | — |
| 104 | LGND | Ligand Pharmaceuticals Incorporated | $285.60 | $5.69B | 29.41 | — |
| 105 | MMSI | Merit Medical Systems, Inc. | $89.60 | $5.35B | 36.87 | — |
| 106 | ACAD | ACADIA Pharmaceuticals Inc. | $28.02 | $4.83B | 12.57 | — |
| 107 | HAE | Haemonetics Corporation | $102.92 | $4.68B | 49.72 | — |
| 108 | DYN | Dyne Therapeutics, Inc. | $24.28 | $4.53B | — | — |
| 109 | LIVN | LivaNova PLC | $81.92 | $4.50B | 24.17 | — |
| 110 | CTEC | Convatec Group PLC | £2.28 | £4.43B | 45.64 | 2.43% |
| 111 | ITGR | Integer Holdings Corporation | $126.50 | $4.30B | 34.56 | — |
| 112 | ICUI | ICU Medical, Inc. | $167.58 | $4.19B | 140.82 | — |
| 113 | IRTC | iRhythm Holdings, Inc. | $123.07 | $4.06B | — | — |
| 114 | ADPT | Adaptive Biotechnologies Corporation | $24.28 | $3.87B | — | — |
| 115 | CPRX | Catalyst Pharmaceuticals Inc | $31.49 | $3.85B | 18.20 | — |
| 116 | PLSE | Pulse Biosciences, Inc. | $53.24 | $3.80B | — | — |
| 117 | NHC | National HealthCare Corporation | $218.64 | $3.42B | 24.57 | 1.23% |
| 118 | VCYT | Veracyte, Inc. | $42.53 | $3.42B | 30.38 | — |
| 119 | HIK | Hikma Pharmaceuticals PLC | £15.93 | £3.30B | 12.25 | 3.98% |
| 120 | CLDX | Celldex Therapeutics, Inc. | $39.68 | $3.12B | — | — |
| 121 | BEAM | Beam Therapeutics Inc. | $29.66 | $3.06B | — | — |
| 122 | RGC | Regencell Bioscience Holdings Limited | $6.89 | $2.72B | — | — |
| 123 | ATRC | AtriCure, Inc. | $51.52 | $2.62B | 245.33 | — |
| 124 | ACHC | Acadia Healthcare Company, Inc. | $28.13 | $2.62B | — | — |
| 125 | AXGN | Axogen, Inc. | $48.28 | $2.60B | — | — |
| 126 | NEOG | Neogen Corporation | $11.83 | $2.58B | — | — |
| 127 | BCRX | BioCryst Pharmaceuticals, Inc. | $9.96 | $2.55B | — | — |
| 128 | NKTR | Nektar Therapeutics | $74.19 | $2.53B | — | — |
| 129 | SUPN | Supernus Pharmaceuticals, Inc. | $43.53 | $2.53B | — | — |
| 130 | PBH | Prestige Consumer Healthcare Inc. | $52.26 | $2.48B | 14.64 | — |
| 131 | SRPT | Sarepta Therapeutics, Inc. | $22.50 | $2.38B | — | — |
| 132 | BHVN | Biohaven Ltd. | $15.69 | $2.37B | — | — |
| 133 | OCUL | Ocular Therapeutix, Inc. | $10.64 | $2.34B | — | — |
| 134 | XRAY | DENTSPLY SIRONA Inc. | $11.38 | $2.27B | — | 5.04% |
| 135 | UFPT | UFP Technologies, Inc. | $288.79 | $2.24B | 31.19 | — |
| 136 | NEO | NeoGenomics, Inc. | $17.38 | $2.23B | — | — |
| 137 | ADUS | Addus HomeCare Corporation | $118.76 | $2.22B | 20.76 | — |
| 138 | MD | Pediatrix Medical Group, Inc. | $27.03 | $2.20B | 12.93 | — |
| 139 | NVCR | NovoCure Limited | $17.94 | $2.09B | — | — |
| 140 | PRGO | Perrigo Company plc | $14.92 | $2.06B | — | 7.77% |
| 141 | XNCR | Xencor, Inc. | $26.61 | $1.98B | — | — |
| 142 | AGIO | Agios Pharmaceuticals, Inc. | $33.10 | $1.98B | — | — |
| 143 | SGRY | Surgery Partners, Inc. | $14.26 | $1.87B | — | — |
| 144 | LMAT | LeMaitre Vascular, Inc. | $80.67 | $1.84B | 28.21 | 1.24% |
| 145 | SNDX | Syndax Pharmaceuticals, Inc. | $20.56 | $1.84B | — | — |
| 146 | INSP | Inspire Medical Systems, Inc. | $63.08 | $1.82B | 13.92 | — |
| 147 | NTLA | Intellia Therapeutics, Inc. | $12.74 | $1.79B | — | — |
| 148 | NVAX | Novavax, Inc. | $10.22 | $1.69B | — | — |
| 149 | ANAB | AnaptysBio, Inc. | $56.80 | $1.68B | — | — |
| 150 | ANIP | ANI Pharmaceuticals, Inc. | $71.23 | $1.64B | 15.52 | — |
| 151 | OMCL | Omnicell, Inc. | $34.37 | $1.56B | 40.92 | — |
| 152 | PAHC | Phibro Animal Health Corporation | $38.25 | $1.55B | 15.74 | 1.25% |
| 153 | INVA | Innoviva, Inc. | $21.33 | $1.54B | 4.95 | — |
| 154 | RARE | Ultragenyx Pharmaceutical Inc. | $15.30 | $1.51B | — | — |
| 155 | AKTS | Aktis Oncology, Inc. | $27.05 | $1.50B | — | — |
| 156 | HCSG | Healthcare Services Group, Inc. | $21.82 | $1.50B | 12.76 | — |
| 157 | AGL | agilon health, inc. | $88.50 | $1.49B | — | — |
| 158 | CNMD | CONMED Corporation | $49.32 | $1.48B | 26.66 | 1.62% |
| 159 | ATEC | Alphatec Holdings, Inc. | $9.45 | $1.46B | — | — |
| 160 | TNDM | Tandem Diabetes Care, Inc. | $19.90 | $1.38B | — | — |
| 161 | OMER | Omeros Corporation | $18.95 | $1.37B | 11.48 | — |
| 162 | AMN | AMN Healthcare Services, Inc. | $33.80 | $1.31B | 12.57 | — |
| 163 | MNKD | MannKind Corporation | $4.06 | $1.31B | — | — |
| 164 | IART | Integra LifeSciences Holdings Corporation | $16.72 | $1.30B | — | — |
| 165 | OPK | OPKO Health, Inc. | $1.64 | $1.22B | — | — |
| 166 | CRVS | Corvus Pharmaceuticals, Inc. | $14.39 | $1.21B | — | — |
| 167 | USPH | U.S. Physical Therapy, Inc. | $79.35 | $1.18B | 466.76 | 2.32% |
| 168 | KURA | Kura Oncology, Inc. | $13.25 | $1.18B | — | — |
| 169 | STAA | STAAR Surgical Company | $23.47 | $1.18B | 293.38 | — |
| 170 | TDOC | Teladoc Health, Inc. | $6.28 | $1.14B | — | — |
| 171 | PCRX | Pacira BioSciences, Inc. | $26.35 | $1.05B | 75.29 | — |
| 172 | GERN | Geron Corporation | $1.57 | $1.01B | — | — |
| 173 | LXRX | Lexicon Pharmaceuticals, Inc. | $2.24 | $996.70M | — | — |
| 174 | AMPH | Amphastar Pharmaceuticals, Inc. | $23.18 | $986.03M | 13.72 | — |
| 175 | ARDX | Ardelyx, Inc. | $3.78 | $975.95M | — | — |
| 176 | QDEL | QuidelOrtho Corporation | $13.97 | $958.00M | — | — |
| 177 | WVE | Wave Life Sciences, Inc. | $4.86 | $957.65M | — | — |
| 178 | RIGL | Rigel Pharmaceuticals, Inc. | $48.67 | $909.15M | 2.88 | — |
| 179 | ACRS | Aclaris Therapeutics, Inc. | $6.17 | $908.22M | — | — |
| 180 | TBPH | Theravance Biopharma, Inc. | $17.08 | $886.77M | 16.42 | — |
| 181 | HSTM | HealthStream, Inc. | $29.20 | $853.81M | 40.56 | 0.47% |
| 182 | CTMX | CytomX Therapeutics, Inc. | $3.71 | $808.41M | — | — |
| 183 | VREX | Varex Imaging Corporation | $18.51 | $780.16M | 34.92 | — |
| 184 | ASMB | Assembly Biosciences, Inc. | $36.60 | $745.20M | 29.52 | — |
| 185 | VSTM | Verastem, Inc. | $8.20 | $742.62M | — | — |
| 186 | COLL | Collegium Pharmaceutical, Inc. | $23.53 | $729.41M | 18.53 | — |
| 187 | XOMA | XOMA Royalty Corp | $40.17 | $710.16M | 25.59 | — |
| 188 | IRWD | Ironwood Pharmaceuticals, Inc. | $4.26 | $703.92M | 5.39 | — |
| 189 | MDXG | MiMedx Group, Inc. | $4.57 | $666.13M | 114.25 | — |
| 190 | ANGO | AngioDynamics, Inc. | $15.20 | $628.25M | — | — |
| 191 | RGNX | REGENXBIO Inc. | $8.94 | $590.16M | — | — |
| 192 | DCTH | Delcath Systems, Inc. | $16.48 | $571.84M | 1,648.00 | — |
| 193 | OVID | Ovid Therapeutics Inc. | $2.80 | $546.83M | — | — |
| 194 | CERS | Cerus Corporation | $2.59 | $521.95M | — | — |
| 195 | MDRX | Veradigm Inc. | $4.74 | $516.62M | — | — |
| 196 | PRTA | Prothena Corporation plc | $9.82 | $504.13M | — | — |
| 197 | EDIT | Editas Medicine, Inc. | $3.23 | $496.06M | — | — |
| 198 | TCMD | Tactile Systems Technology, Inc. | $21.87 | $495.41M | 20.44 | — |
| 199 | PBYI | Puma Biotechnology, Inc. | $9.55 | $492.97M | 18.73 | — |
| 200 | EVH | Evolent Health, Inc. | $4.32 | $488.42M | — | — |
| 201 | DNA | Ginkgo Bioworks Holdings, Inc. | $6.95 | $468.01M | — | — |
| 202 | CCRN | Cross Country Healthcare Inc | $13.25 | $428.06M | — | — |
| 203 | PACB | Pacific Biosciences of California, Inc. | $1.35 | $419.62M | — | — |
| 204 | ENTA | Enanta Pharmaceuticals, Inc. | $14.08 | $410.09M | — | — |
| 205 | CYH | Community Health Systems, Inc. | $2.89 | $407.52M | 1.56 | — |
| 206 | OFIX | Orthofix Medical Inc. | $9.29 | $375.52M | — | — |
| 207 | SLP | Simulations Plus, Inc. | $18.43 | $372.74M | 46.08 | — |
| 208 | AGEN | Agenus Inc. | $8.24 | $370.88M | 2.76 | — |
| 209 | ABEO | Abeona Therapeutics Inc. | $6.00 | $343.10M | — | — |
| 210 | VNDA | Vanda Pharmaceuticals Inc. | $5.43 | $328.31M | — | — |
| 211 | EBS | Emergent BioSolutions Inc. | $6.21 | $318.41M | — | — |
| 212 | MYGN | Myriad Genetics, Inc. | $3.19 | $305.12M | — | — |
| 213 | FATE | Fate Therapeutics, Inc. | $2.48 | $297.15M | — | — |
| 214 | MGNX | MacroGenics, Inc. | $4.40 | $280.28M | — | — |
| 215 | ANIK | Anika Therapeutics, Inc. | $20.81 | $278.50M | — | — |
| 216 | SY | So-Young International Inc. | $2.76 | $277.70M | — | — |
| 217 | CAMP | CAMP4 THERAPEUTICS CORPORATION | $4.41 | $276.74M | — | — |
| 218 | AKBA | Akebia Therapeutics, Inc. | $0.97 | $270.10M | — | — |
| 219 | LAB | Standard BioTools Inc. | $0.69 | $269.11M | — | — |
| 220 | AVXL | Anavex Life Sciences Corp. | $2.86 | $265.11M | — | — |
| 221 | OSUR | OraSure Technologies, Inc. | $3.48 | $240.01M | — | — |
| 222 | SIGA | SIGA Technologies, Inc. | $3.29 | $236.39M | — | — |
| 223 | UTMD | Utah Medical Products, Inc. | $71.10 | $226.37M | 21.68 | 1.75% |
| 224 | SPOK | Spok Holdings, Inc. | $10.71 | $224.03M | 18.79 | 11.67% |
| 225 | DERM | Journey Medical Corporation | $7.86 | $221.84M | — | — |
| 226 | CHRS | Coherus Oncology, Inc. | $1.42 | $219.39M | — | — |
| 227 | VYGR | Voyager Therapeutics, Inc. | $3.51 | $216.28M | — | — |
| 228 | PLX | Protalix BioTherapeutics, Inc. | $2.67 | $215.13M | 11.61 | — |
| 229 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | $11.08 | $214.30M | — | — |
| 230 | NERV | Minerva Neurosciences, Inc. | $4.43 | $211.52M | — | — |
| 231 | WW | WW International, Inc. | $18.02 | $180.18M | 1.56 | — |
| 232 | ADCT | ADC Therapeutics SA | $1.36 | $173.63M | — | — |
| 233 | CDXS | Codexis, Inc. | $1.46 | $159.88M | — | — |
| 234 | INO | Inovio Pharmaceuticals, Inc. | $1.43 | $147.86M | — | — |
| 235 | INGN | Inogen, Inc. | $5.42 | $143.84M | — | — |
| 236 | STXS | Stereotaxis, Inc. | $1.39 | $139.28M | — | — |
| 237 | VTVT | vTv Therapeutics Inc. | $33.35 | $131.86M | — | — |
| 238 | ATRA | Atara Biotherapeutics, Inc. | $9.76 | $97.97M | — | — |
| 239 | FBIO | Fortress Biotech, Inc. | $2.72 | $90.71M | 0.98 | — |
| 240 | ACET | Adicet Bio, Inc. | $9.59 | $89.78M | — | — |
| 241 | INCR | InterCure Ltd. | $5.42 | $81.32M | — | — |
| 242 | MNOV | MediciNova, Inc. | $1.63 | $80.23M | — | — |
| 243 | XBIT | XBiotech Inc. | $2.20 | $67.07M | — | — |
| 244 | HRTX | Heron Therapeutics, Inc. | $0.34 | $65.29M | — | — |
| 245 | MCRB | Seres Therapeutics, Inc. | $5.72 | $57.46M | — | — |
| 246 | KPTI | Karyopharm Therapeutics Inc. | $1.79 | $40.60M | — | — |
| 247 | PETS | PetMed Express, Inc. | $1.81 | $39.24M | — | — |
| 248 | HBIO | Harvard Bioscience, Inc. | $8.02 | $36.51M | — | — |
| 249 | RMTI | Rockwell Medical, Inc. | $7.99 | $32.18M | — | — |
| 250 | ARAY | Accuray Incorporated | $0.27 | $31.87M | — | — |
| 251 | TXMD | TherapeuticsMD, Inc. | $2.21 | $25.58M | — | — |
| 252 | BEAT | HeartBeam, Inc. | $0.43 | $24.05M | — | — |
| 253 | BOLT | Bolt Biotherapeutics, Inc. | $3.90 | $7.51M | — | — |
| 254 | XRTX | XORTX Therapeutics Inc. | $2.31 | $4.20M | — | — |
| 255 | ARTL | Artelo Biosciences, Inc. | $6.04 | $3.31M | — | — |
| 256 | EGRX | Eagle Pharmaceuticals, Inc. | $0.25 | $3.29M | 1.25 | — |
| 257 | CRIS | Curis, Inc. | $1.35 | $3.27M | 0.37 | — |
| 258 | MTNB | Matinas BioPharma Holdings, Inc. | $0.18 | $2.67M | — | — |
| 259 | DMAN | Demand Brands, Inc. | $0.00 | $591,495 | inf | — |
| 260 | AMPE | Ampio Pharmaceuticals, Inc. | $0.18 | $207,884 | — | — |
| 261 | ARYX | ARYx Therapeutics Inc | $0.00 | $16,730 | — | — |
| 262 | SYRS | Syros Pharmaceuticals, Inc. | $0.00 | $10,732 | — | — |
| 263 | TRVN | Trevena, Inc. | $0.01 | $9,501 | — | — |
| 264 | ACUR | Acura Pharmaceuticals, Inc. | $0.00 | $6,600 | — | — |
| 265 | ANTH | Anthera Pharmaceuticals, Inc. | $0.00 | $2,617 | — | — |
| 266 | VIVE | Viveve Medical, Inc. | $0.00 | $2,144 | — | — |
| 267 | BGMD | BG Medicine, Inc. | $0.00 | $1,137 | — | — |
Further Reading
AMAZON
One Up On Wall Street
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →
AMAZON
Stock Trading Journal
A structured logbook for tracking positions, theses and outcomes over time.
Check Price →
AMAZON
The Psychology of Money
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →